Metformin-induced preferential killing of breast cancer initiating CD44+CD24−/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts (Q36050677)
scientific article published on April 1, 2012
Language:
Current Data About Metformin-induced preferential killing of breast cancer initiating CD44+CD24−/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
(P31) (Q13442814)
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

(P50) (Q60976112)
(P1545) 7
(P1932) Begoña Martin-Castillo
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

(Q41878554)
(P1545) 6
(P1932) Joaquim Bosch-Barrera
(P248)
(P698) 22565037
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22565037
(P813) Tuesday, December 31, 2024

(P304) 395-398
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

(P478) 3
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

(P577) Sunday, April 1, 2012
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

Sunday, April 1, 2012
(P248)
(P698) 22565037
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22565037
(P813) Tuesday, December 31, 2024

(P921) (Q19484)
(P887)

(Q64148587)
(P887)

(Q128581)
(P887)

(Q412616)
(P887)

(P953) https://www.oncotarget.com/article/488/pdf/
(P2701)
(P6954)
(P248)
(P698) 22565037
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22565037
(P813) Tuesday, December 31, 2024

https://europepmc.org/articles/PMC3380574
(P2701)
(P6954)
(P3274)
(P248)
(P698) 22565037
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22565037
(P813) Tuesday, December 31, 2024

https://europepmc.org/articles/PMC3380574?pdf=render
(P2701)
(P6954)
(P3274)
(P248)
(P698) 22565037
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22565037
(P813) Tuesday, December 31, 2024

https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.488
(P248)
(P356) 10.18632/ONCOTARGET.488
(P854) https://api.crossref.org/works/10.18632/ONCOTARGET.488
(P813) Tuesday, December 31, 2024

(P1433) (Q1573155)
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

(P1476) "Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts" (language: en)
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

"Metformin-induced preferential killing of breast cancer initiating CD44+CD24−/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts" (language: en)
(P248)
(P356) 10.18632/ONCOTARGET.488
(P854) https://api.crossref.org/works/10.18632/ONCOTARGET.488
(P813) Tuesday, December 31, 2024

(P2093) Silvia Cufi
(P1545) 1
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

Bruna Corominas-Faja
(P1545) 2
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

Alejandro Vazquez-Martin
(P1545) 3
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

Christina Oliveras-Ferraros
(P1545) 4
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

Joan Dorca
(P1545) 5
(P248)
(P932) 3380574
(P813) Friday, August 11, 2017

Javier A. Menendez
(P1545) 8
(P248)
(P698) 22565037
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22565037
(P813) Tuesday, December 31, 2024

(P2860) (Q34899382)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q39674865)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q39703892)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q39705415)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q39733674)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q34611836)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q37406061)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q40185009)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q40474432)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Monday, October 2, 2017

(Q43250098)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3380574
(P813) Sunday, September 23, 2018

(Q95792217)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/22565037
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article published on April 1, 2012

External Links
(P356) 10.18632/ONCOTARGET.488
(P698) 22565037
(P932) 3380574
(P5875) 224917484